GLP-1 drugs, also known as GLP-1 agonists, stimulate the pancreas to release insulin and suppress glucagon, another hormone that raises blood sugar
Key takeaways: Acute pancreatitis is a painful, severe inflammation of the pancreas
We don't have robust long-term data on: What happens to muscle mass and bone density over 5-10 years of use The impact on people who start these medications in their 20s or 30s Impact on fertility/reproductive outcomes Early data is showing that GLP-1 might help in PCOS, but what about long-term hormonal regulation
Skov J, Dejgaard A, Frkir J, Holst JJ, Jonassen T, Rittig S, Christiansen JS
Disruptions in this fragile equilibrium lead to metabolic and gastrointestinal diseases, highlighting the profound impact of the gut microbiota on the host intestinal metabolic processes
Zhao X, Wang M, Wen Z, Lu Z, Cui L, Fu C, Xue H, Liu Y, Zhang Y (2021) GLP-1 receptor agonists: beyond their pancreatic effects